Company: MIRA
Filing Date: 2025-06-17
Form Type: PREM14A
Source: 0001641172-25-015340
Chunk: 94

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-06-17
Form: PREM14A
Chunk 94
---
 and managerial resources in the defense of our intellectual property rights in the future if we believe that our rights have been violated. We also anticipate that we will expend significant financial and managerial resources to defend against claims that our products and services infringe upon the intellectual property rights of third parties.

| 52 |

<div align='center'>PRINCIPAL STOCKHOLDERS OF MIRA PHARMACEUTICALS, INC.</div>

The following table sets forth, as of the date of this proxy statement, the ownership of our securities by: (i) each of our directors, (ii) all persons who, to our knowledge, are the beneficial owners of more than 5% of the outstanding shares of common stock, (iii) each of the executive officers, and (iv) all of our directors and executive officers, as a group. Each person named in this table has sole investment power and sole voting power with respect to the shares of common stock set forth opposite such person’s name, except as otherwise indicated.

The following table is based upon information supplied by officers, directors and principal stockholders and Schedules 13G filed with the SEC. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, MIRA believes that each of the stockholders named in this table has sole voting and investment power with respect to the shares indicated as beneficially owned. Applicable percentages are based on 17,385,140 shares outstanding on June 10, 2025, adjusted as required by rules promulgated by the SEC.

| Name and Address                
 of Beneficial Owner             |     | Amount               
 and Nature of        
 Beneficial Ownership |           |     | Percentage 
 of Class   |       |   |
| Directors                       
 and Executive Officers (1)      |     |                      |           |     |            |       |   |
| Erez Aminov (2)                 |     |                      | 4,011,200 |     |            | 19.23 | % |
| Alan Weichselbaum               |     |                      |         - |     |            |     * |   |
| Matthew Whalen                  |     |                      |         - |     |            |     * |   |
| Matthew Del Giudice             |     |                      |    25,000 |     |            |     * |   |
| Denil Nanji Shekhat             |     |                      |    41,666 |     |            |     * |